168 related articles for article (PubMed ID: 37802683)
21. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
22. Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.
Liu J; Lai S; Wu P; Wang J; Wang J; Wang J; Zhang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10893-10909. PubMed ID: 37318591
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
[TBL] [Abstract][Full Text] [Related]
24. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
25. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma.
Powles T; Assaf ZJ; Degaonkar V; Grivas P; Hussain M; Oudard S; Gschwend JE; Albers P; Castellano D; Nishiyama H; Daneshmand S; Sharma S; Sethi H; Aleshin A; Shi Y; Davarpanah N; Carter C; Bellmunt J; Mariathasan S
Eur Urol; 2024 Feb; 85(2):114-122. PubMed ID: 37500339
[TBL] [Abstract][Full Text] [Related]
26. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
Petros FG; Choi W; Qi Y; Moss T; Li R; Su X; Guo CC; Czerniak B; Dinney C; McConkey DJ; Matin SF
J Urol; 2021 Sep; 206(3):548-557. PubMed ID: 33881933
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
[TBL] [Abstract][Full Text] [Related]
28. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
29. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.
Favaretto RL; Shariat SF; Chade DC; Godoy G; Adamy A; Kaag M; Bochner BH; Coleman J; Dalbagni G
Eur Urol; 2010 Oct; 58(4):574-80. PubMed ID: 20637540
[TBL] [Abstract][Full Text] [Related]
30. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
[TBL] [Abstract][Full Text] [Related]
31. Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States.
Singla N; Fang D; Su X; Bao Z; Cao Z; Robyak H; Xiong G; Zhang L; Woldu S; Hutchinson R; Sagalowsky A; Lotan Y; Li X; Zhou L; Raman JD; Margulis V
Urol Oncol; 2018 Mar; 36(3):88.e11-88.e18. PubMed ID: 29174945
[TBL] [Abstract][Full Text] [Related]
32. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.
Nison L; Rouprêt M; Bozzini G; Ouzzane A; Audenet F; Pignot G; Ruffion A; Cornu JN; Hurel S; Valeri A; Roumiguie M; Polguer T; Hoarau N; Mérigot de Treigny O; Xylinas E; Matte A; Droupy S; Fais PO; Descazeaud A; Colin P;
World J Urol; 2013 Feb; 31(1):69-76. PubMed ID: 23070533
[TBL] [Abstract][Full Text] [Related]
33. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
34. Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma.
Kobayashi S; Ito M; Takemura K; Suzuki H; Yonese I; Koga F
Int J Clin Oncol; 2022 Mar; 27(3):574-584. PubMed ID: 34860315
[TBL] [Abstract][Full Text] [Related]
35. Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy.
Carrion A; Huguet J; García-Cruz E; Izquierdo L; Mateu L; Musquera M; Ribal MJ; Alcaraz A
Scand J Urol; 2016 Aug; 50(4):305-12. PubMed ID: 26926709
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological and Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients with Upper Urinary Tract Urothelial Carcinoma.
Liu J; Wu P; Lai S; Song X; Wang M; Wang X; Liu S; Hou H; Zhang Y; Wang J
Nutr Cancer; 2022; 74(8):2964-2974. PubMed ID: 35297733
[TBL] [Abstract][Full Text] [Related]
37. The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
van Doeveren T; Nakauma-Gonzalez JA; Mason AS; van Leenders GJLH; Zuiverloon TCM; Zwarthoff EC; Meijssen IC; van der Made AC; van der Heijden AG; Hendricksen K; van Rhijn BWG; Voskuilen CS; van Riet J; Dinjens WNM; Dubbink HJ; van de Werken HJG; Boormans JL
Int J Cancer; 2021 Feb; 148(4):981-987. PubMed ID: 33006377
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
[TBL] [Abstract][Full Text] [Related]
40. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
